vs

Side-by-side financial comparison of INSMED Inc (INSM) and PicoCELA Inc. (PCLA). Click either name above to swap in a different company.

INSMED Inc is the larger business by last-quarter revenue ($263.8M vs $252.6M, roughly 1.0× PicoCELA Inc.). INSMED Inc runs the higher net margin — -124.5% vs -125.2%, a 0.7% gap on every dollar of revenue. PicoCELA Inc. produced more free cash flow last quarter ($-256.6M vs $-264.2M).

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

PicoCELA Inc. is a global technology company specializing in low-power, high-reliability wireless connectivity solutions, including Wi-Fi HaLow modules and edge network infrastructure. It caters to industrial IoT, smart city, retail, and smart home segments, with a primary operational footprint across Asia, North America, and European markets.

INSM vs PCLA — Head-to-Head

Bigger by revenue
INSM
INSM
1.0× larger
INSM
$263.8M
$252.6M
PCLA
Higher net margin
INSM
INSM
0.7% more per $
INSM
-124.5%
-125.2%
PCLA
More free cash flow
PCLA
PCLA
$7.6M more FCF
PCLA
$-256.6M
$-264.2M
INSM

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
INSM
INSM
PCLA
PCLA
Revenue
$263.8M
$252.6M
Net Profit
$-328.5M
$-316.2M
Gross Margin
83.2%
Operating Margin
-121.2%
-114.8%
Net Margin
-124.5%
-125.2%
Revenue YoY
152.6%
Net Profit YoY
-39.5%
EPS (diluted)
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSM
INSM
PCLA
PCLA
Q4 25
$263.8M
Q3 25
$142.3M
Q2 25
$107.4M
Q1 25
$92.8M
$252.6M
Q4 24
$104.4M
Q3 24
$93.4M
Q2 24
$90.3M
Q1 24
$75.5M
Net Profit
INSM
INSM
PCLA
PCLA
Q4 25
$-328.5M
Q3 25
$-370.0M
Q2 25
$-321.7M
Q1 25
$-256.6M
$-316.2M
Q4 24
$-235.5M
Q3 24
$-220.5M
Q2 24
$-300.6M
Q1 24
$-157.1M
Gross Margin
INSM
INSM
PCLA
PCLA
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
75.0%
Q3 24
77.3%
Q2 24
76.8%
Q1 24
76.9%
Operating Margin
INSM
INSM
PCLA
PCLA
Q4 25
-121.2%
Q3 25
-257.1%
Q2 25
-291.3%
Q1 25
-267.3%
-114.8%
Q4 24
-220.6%
Q3 24
-228.4%
Q2 24
-319.8%
Q1 24
-192.7%
Net Margin
INSM
INSM
PCLA
PCLA
Q4 25
-124.5%
Q3 25
-260.0%
Q2 25
-299.5%
Q1 25
-276.4%
-125.2%
Q4 24
-225.5%
Q3 24
-236.0%
Q2 24
-332.8%
Q1 24
-208.1%
EPS (diluted)
INSM
INSM
PCLA
PCLA
Q4 25
$-1.55
Q3 25
$-1.75
Q2 25
$-1.70
Q1 25
$-1.42
Q4 24
$-1.30
Q3 24
$-1.27
Q2 24
$-1.94
Q1 24
$-1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSM
INSM
PCLA
PCLA
Cash + ST InvestmentsLiquidity on hand
$1.4B
$456.8M
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$739.0M
$354.8M
Total Assets
$2.3B
$1.2B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSM
INSM
PCLA
PCLA
Q4 25
$1.4B
Q3 25
$1.7B
Q2 25
$1.9B
Q1 25
$1.2B
$456.8M
Q4 24
$1.4B
Q3 24
$1.5B
Q2 24
$1.2B
Q1 24
$595.7M
Total Debt
INSM
INSM
PCLA
PCLA
Q4 25
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$971.8M
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
INSM
INSM
PCLA
PCLA
Q4 25
$739.0M
Q3 25
$945.6M
Q2 25
$1.2B
Q1 25
$99.2M
$354.8M
Q4 24
$285.4M
Q3 24
$483.4M
Q2 24
$38.8M
Q1 24
$-464.8M
Total Assets
INSM
INSM
PCLA
PCLA
Q4 25
$2.3B
Q3 25
$2.4B
Q2 25
$2.5B
Q1 25
$1.8B
$1.2B
Q4 24
$2.0B
Q3 24
$2.1B
Q2 24
$1.8B
Q1 24
$1.2B
Debt / Equity
INSM
INSM
PCLA
PCLA
Q4 25
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
3.93×
Q3 24
2.01×
Q2 24
30.66×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSM
INSM
PCLA
PCLA
Operating Cash FlowLast quarter
$-247.6M
$-245.6M
Free Cash FlowOCF − Capex
$-264.2M
$-256.6M
FCF MarginFCF / Revenue
-100.1%
-101.6%
Capex IntensityCapex / Revenue
6.3%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSM
INSM
PCLA
PCLA
Q4 25
$-247.6M
Q3 25
$-219.8M
Q2 25
$-205.6M
Q1 25
$-262.1M
$-245.6M
Q4 24
$-196.0M
Q3 24
$-180.9M
Q2 24
$-123.0M
Q1 24
$-184.0M
Free Cash Flow
INSM
INSM
PCLA
PCLA
Q4 25
$-264.2M
Q3 25
$-222.2M
Q2 25
$-209.1M
Q1 25
$-272.2M
$-256.6M
Q4 24
$-202.8M
Q3 24
$-184.6M
Q2 24
$-129.7M
Q1 24
$-188.7M
FCF Margin
INSM
INSM
PCLA
PCLA
Q4 25
-100.1%
Q3 25
-156.1%
Q2 25
-194.6%
Q1 25
-293.2%
-101.6%
Q4 24
-194.1%
Q3 24
-197.6%
Q2 24
-143.6%
Q1 24
-250.0%
Capex Intensity
INSM
INSM
PCLA
PCLA
Q4 25
6.3%
Q3 25
1.7%
Q2 25
3.2%
Q1 25
10.8%
4.3%
Q4 24
6.5%
Q3 24
3.9%
Q2 24
7.5%
Q1 24
6.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INSM
INSM

Segment breakdown not available.

PCLA
PCLA

Revenue from product$179.1M71%
Revenue from SaaS, Maintenance and others$42.4M17%
Revenue from product – related party$31.0M12%

Related Comparisons